Cannabis and Opioids: Latest Research on Substitution and Pain

Current Research on Cannabis and Opioid Reduction

As the opioid epidemic continues to impact communities nationwide, medical professionals and researchers are exploring alternative approaches to pain management and opioid dependence. Recent peer-reviewed studies published in PubMed, the U.S. National Library of Medicine’s database of medical research, shed light on the potential role of cannabis in these areas. While the science is still evolving, these findings offer valuable insights for patients and healthcare providers alike.

Cannabis for Mental Health and Substance Use Disorders

A 2025 systematic review and meta-analysis in The Lancet Psychiatry examined the efficacy and safety of cannabinoids as a primary treatment for mental disorders and substance use disorders (SUDs). The study analyzed randomized controlled trials (RCTs) to determine whether cannabinoids could effectively address these conditions. While the research identified some potential benefits, it also highlighted the need for more rigorous studies to establish clear safety and efficacy profiles. Patients considering cannabis for mental health or SUDs should consult their physician to discuss personalized options.

Cannabidiol (CBD) and Opioid Analgesia

Another study, published in The Journal of Pain, investigated the effects of cannabidiol (CBD) on opioid analgesia in rats. Researchers explored whether CBD could enhance the pain-relieving effects of oxycodone while reducing its reward-related effects, which contribute to dependence. The findings suggested that CBD might offer selective opioid-sparing effects, meaning it could potentially lower the dose of opioids needed for pain relief. However, this study was conducted on animals, and further human trials are necessary to confirm these effects.

Cannabinoids and Opioid Consumption in Cancer Pain

A systematic review and meta-analysis in Supportive Care in Cancer focused on the impact of cannabinoids on opioid consumption in cancer patients experiencing pain. The study reviewed clinical trials, both randomized and nonrandomized, involving adults with cancer-related pain. The results indicated that cannabinoids might help reduce opioid use in these patients, though the findings were mixed, and more research is needed to determine optimal dosing and long-term effects. As always, patients should discuss their pain management plan with their healthcare provider.

Cannabis in Anesthesia and Postoperative Pain

Research in Minerva Anestesiologica explored the interaction between cannabis and anesthesia, particularly in the context of postoperative pain management. The study noted that cannabis, particularly THC and CBD, can influence the body’s response to anesthetic drugs and affect cardiovascular, respiratory, and neurological systems. While the findings suggest that cannabis might play a role in reducing postoperative opioid use, the study also emphasized the need for caution, as chronic or high-dose cannabis use could alter anesthetic requirements and increase perioperative risks.

What This Means for Patients

The research on cannabis and opioids is still developing, and while these studies offer promising insights, they do not provide definitive answers. Cannabis may have the potential to reduce opioid use in certain scenarios, but individual responses vary, and more clinical trials are needed to establish clear guidelines. Patients who are considering cannabis as part of their pain management or opioid reduction strategy should always consult a licensed physician to discuss their specific needs and risks.

If you or a loved one are exploring cannabis as a treatment option, Compassionate Alternative Care can help guide you through the process of obtaining a medical marijuana card in Florida. Our team is dedicated to providing compassionate, evidence-based care to support your health journey. Talk to your physician today to learn more.